2022 Annual Northwest Oncology Nursing Summit: Focusing on Precision Oncology

Seattle, WA US
October 22, 2022

The "2022 Annual Northwest Oncology Nursing Summit – focusing on precision oncology" is a one-day CE-accredited in-person conference. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and solid tumors.  The program features in-depth discussion and analysis of recently reported clinical trial data that are relevant to the management of patients with cancer. Expert faculty will utilize various formats including didactics and case-based discussions to convey the latest information in a practical and applicable way. Expert faculty will aim to place the role of different therapeutic agents in the clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. They will discuss strategies to help healthcare professionals optimize patient management and provide insight into the evolving treatment landscape for a variety of malignancies. 

Case-based discussion and audience response system will be used to create an interactive program to identify barriers and ways to navigate those barriers to optimize the delivery of care for patients with cancer. Question and answer sessions will provide an opportunity to engage with faculty as they share their experiences with clinical challenges commonly encountered in nursing practice. 

Target Audience

  • Oncology nurses
  • Oncology nurse practitioners
  • Oncology physician assistants
  • Oncology pharmacists
  • Other healthcare professionals involved in the management of patients with cancer 

 

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Review recently reported clinical trial data that are relevant for the management of patients with solid and hematologic malignancies
  • Discuss the role of novel molecular abnormalities, prognostic markers, and their implications in decision-making in patients with cancer
  • Identify and manage adverse events associated with immunotherapies, targeted therapies, and other current or emerging agents in oncology.
  • Identify barriers and review ways to navigate those barriers to optimize the delivery of care for patients with cancer.   
Course summary
Available credit: 
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
Course opens: 
01/01/2022
Course expires: 
11/22/2022
Event starts: 
10/22/2022 - 7:00am PDT
Event ends: 
10/22/2022 - 4:15pm PDT
Cost:
$850.00

7:00 AM to 8:00 AM: Registration, Breakfast & Exhibits


08:00 AM – 08:15 AM: Welcome remarks


SESSION 1
08:15 AM – 08:35 AM: Updates on the management of leukemia
08:35 AM – 08:55 AM: Advances in the management of lymphoma
08:55 AM – 09:15 AM: Nursing perspectives on CAR-T therapy
09:15 AM – 09:45 AM: Panel discussion/Q & A


09:45 AM – 10:15 AM: Break/Exhibits


SESSION 2
10:15 AM – 10:35 AM: New therapies for breast cancer
10:35 AM – 10:55 AM: Precision therapy in lung cancer
10:55 AM – 11:15 AM: Novel approaches to the management of GU cancers
11:15 AM – 11:45 AM: Panel discussion/Q & A


11:45 AM – 01:00 PM: Lunch/Exhibits


SESSION 3
01:00 PM – 01:20 PM: Identification and management of toxicities of immunotherapy
01:20 PM – 01:40 PM: Approaches to improve adherence to oral chemotherapy – a case-based discussion
01:40 PM – 02:00 PM: How to optimize chemotherapy education – a case-based discussion
02:00 PM – 02:20 PM: Nurse navigation in the era of precision oncology
02:20 PM – 03:00 PM: Panel discussion/Q & A


03:00 PM - 3:15 PM: Break & Exhibits


SESSION 4
03:15 PM - 4:15 PM: Cancer Screening & early cancer detection session
03:15 PM - 3:35 PM: Cancer screening guidelines: current updates
03:35 PM - 3:55 PM: Cell-Free DNA sequencing for early cancer detection
03:55 PM - 4:15 PM: Panel discussion/Q & A


4:15 PM: Adjourn

Grand Hyatt Seattle
721 Pine St
Seattle, WA 98101
United States

A limited number of rooms have been reserved for the attendees of this conference at the Grand Hyatt Seattle at the discounted rate of $219 per night. All reservations must be made by September 30th to receive the discounted rate. Please go to the link below to reserve your room:

https://www.hyatt.com/en-US/group-booking/SEAGH/G-BOCT

FACULTY INFORMATION COMING SOON

 

Speaker(s)

Jennifer Jacky, ARNP

has no relevant financial relationships to disclose at this time.

Erin Mullane, DNP, ARNP, FNP-C

has no relevant financial relationships to disclose at this time.

Jenn Pingul

has no relevant financial relationships to disclose at this time.

Dorothy Todd

has no relevant financial relationships to disclose at this time.

Available Credit

  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.

If you have signed up to exhibit at our Thoracic Oncology Conference on 10/22/22 at the Grand Hyatt, Seattle, your exhibit fee covers exhibiting at this conference as well. 

If you have NOT signed up to exhibit at our Thoracic Oncology Conference on 10/22/22 at the Grand Hyatt, Seattle, but are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

Price

Cost:
$850.00
Please login or register to take this course.

Registration fees:

Early Bird Registration Deadline: October 1, 2022

  • Anyone employed by the industry - $850
  • APRN/RN/PharmD/PA not employed by the industry - $75
  • Nursing students and other health students (without an HCP License) - $50

 Registration fees on and after October 2, 2022

  • Anyone employed by the industry - $950
  • APRN/RN/PharmD/PA not employed by the industry - $125
  • Nursing students and other health students (without an HCP License) - $100